NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress

Brain Research

Volumn 1476, Issue , 2012, Pages 203-210

  Sarnico, Ilenia ^a   Branca, Caterina ^a   Lanzillotta, Annamaria ^a   Porrini, Vanessa ^a   Benarese, Marina ^a   Spano, Pier Franco ^a,b   Pizzi, Marina ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

Epigenetic; NF B; OGD; Preconditioning; RelA acetylation; Resveratrol

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

BRAIN FUNCTION; CELL STRESS; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; DRUG TARGETING; EPIGENETICS; HISTONE ACETYLATION; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; EPIGENESIS, GENETIC; HUMANS; MODELS, BIOLOGICAL; NEURONS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84866944013     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.04.013     Document Type: Review

References (92)

1. C. Aguilera, R. Hoya-Arias, G. Haegeman, L. Espinosa, and A. Bigas Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression Proc. Natl. Acad. Sci. U. S. A. 101 2004 16537 16542
2. K.T. Akama, C. Albanese, R.G. Pestell, and L.J. Van Eldik Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism Proc. Natl. Acad. Sci. U. S. A. 95 1998 5795 5800
3. B.P. Ashburner, S.D. Westerheide, and A.S. Baldwin Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression Mol. Cell. Biol. 21 2001 7065 7077
4. P.J. Barnes, and M. Karin Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases N. Engl. J. Med. 336 1997 1066 1071
5. S.L. Berger The complex language of chromatin regulation during transcription Nature 447 2007 407 412
6. A. Bird Perceptions of epigenetics Nature 447 2007 396 398
7. L. Blackwell, J. Norris, C.M. Suto, and W.P. Janzen The use of diversity profiling to characterize chemical modulators of the histone deacetylases Life Sci. 82 2008 1050 1058
8. N. Blondeau, C. Widmann, M. Lazdunski, and C. Heurteaux Activation of the nuclear factor-kappaB is a key event in brain tolerance J. Neurosci. 21 2001 4668 4677
9. G. Bonizzi, and M. Karin The two NF-kappaB activation pathways and their role in innate and adaptive immunity Trends Immunol. 25 2004 280 288
10. S.W. Buck, C.M. Gallo, and J.S. Smith Diversity in the Sir2 family of protein deacetylases J. Leukoc. Biol. 75 2004 939 950
11. S. Camelo, A.H. Iglesias, D. Hwang, B. Due, H. Ryu, K. Smith, S.G. Gray, J. Imitola, G. Duran, B. Assaf, B. Langley, S.J. Khoury, G. Stephanopoulos, U. De Girolami, R.R. Ratan, R.J. Ferrante, and F. Dangond Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis J. Neuroimmunol. 164 2005 10 21
12. K.J. Campbell, and N.D. Perkins Reprogramming RelA Cell Cycle 3 2004 869 872
13. G. Cao, W. Pei, H. Ge, Q. Liang, Y. Luo, F.R. Sharp, A. Lu, R. Ran, S.H. Graham, and J. Chen In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis J. Neurosci. 22 2002 5423 5431
14. J.G. Chang, H.M. Hsieh-Li, Y.J. Jong, N.M. Wang, C.H. Tsai, and H. Li Treatment of spinal muscular atrophy by sodium butyrate Proc. Natl. Acad. Sci. U. S. A. 98 2001 9808 9813
15. L.F. Chen, and W.C. Greene Shaping the nuclear action of NF-kappaB Nat. Rev. Mol. Cell Biol. 5 2004 392 401
16. L.F. Chen, W. Fischle, E. Verdin, and W.C. Greene Duration of nuclear NF-kappaB action regulated by reversible acetylation Science 293 2001 1653 1657
17. L.F. Chen, Y. Mu, and W.C. Greene Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB EMBO J. 21 2002 6539 6548
18. L.F. Chen, S.A. Williams, Y. Mu, H. Nakano, J.M. Duerr, L. Buckbinder, and W.C. Greene NF-kappaB RelA phosphorylation regulates RelA acetylation Mol. Cell. Biol. 25 2005 7966 7975
19. J.A. Clemens, D.T. Stephenson, E.B. Smalstig, E.P. Dixon, and S.P. Little Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats Stroke 28 1997 1073 1081
20. L.J. Corcoran, T.J. Mitchison, and Q. Liu A novel action of histone deacetylase inhibitors in a protein aggresome disease model Curr. Biol. 14 2004 488 492
21. P.J. Crack, J.M. Taylor, U. Ali, A. Mansell, and P.J. Hertzog Potential contribution of NF-kappaB in neuronal cell death in the glutathione peroxidase-1 knockout mouse in response to ischemia-reperfusion injury Stroke 37 2006 1533 1538
22. A. De Sario Clinical and molecular overview of inherited disorders resulting from epigenomic dysregulation Eur. J. Med. Genet. 52 2009 363 372
23. E. Dejardin The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development Biochem. Pharmacol. 72 2006 1161 1179
24. G. Egger, G. Liang, A. Aparicio, and P.A. Jones Epigenetics in human disease and prospects for epigenetic therapy Nature 429 2004 457 463
25. M. Fagiolini, C.L. Jensen, and F.A. Champagne Epigenetic influences on brain development and plasticity Curr. Opin. Neurobiol. 19 2009 207 212
26. R.J. Ferrante, J.K. Kubilus, J. Lee, H. Ryu, A. Beesen, B. Zucker, K. Smith, N.W. Kowall, R.R. Ratan, R. Luthi-Carter, and S.M. Hersch Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice J. Neurosci. 23 2003 9418 9427
27. R.A. Frye Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins Biochem. Biophys. Res. Commun. 273 2000 793 798
28. B. Furia, L. Deng, K. Wu, S. Baylor, K. Kehn, H. Li, R. Donnelly, T. Coleman, and F. Kashanchi Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins J. Biol. Chem. 277 2002 4973 4980
29. G. Gardian, S.E. Browne, D.K. Choi, P. Klivenyi, J. Gregorio, J.K. Kubilus, H. Ryu, B. Langley, R.R. Ratan, R.J. Ferrante, and M.F. Beal Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease J. Biol. Chem. 280 2005 556 563
30. M.E. Gerritsen, A.J. Williams, A.S. Neish, S. Moore, Y. Shi, and T. Collins CREB-binding protein/p300 are transcriptional coactivators of p65 Proc. Natl. Acad. Sci. U. S. A. 94 1997 2927 2932
31. S. Ghosh, M.J. May, and E.B. Kopp NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses Annu. Rev. Immunol. 16 1998 225 260
32. F. Goffi, F. Boroni, M. Benarese, I. Sarnico, A. Benetti, P.F. Spano, and M. Pizzi The inhibitor of I kappa B alpha phosphorylation BAY 11-7082 prevents NMDA neurotoxicity in mouse hippocampal slices Neurosci. Lett. 377 2005 147 151
33. M. Grilli, and M. Memo Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway Cell Death Differ. 6 1999 22 27
34. M. Grilli, M. Pizzi, M. Memo, and P. Spano Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation Science 274 1996 1383 1385
35. M. Guttman, I. Amit, M. Garber, C. French, M.F. Lin, D. Feldser, M. Huarte, O. Zuk, B.W. Carey, J.P. Cassady, M.N. Cabili, R. Jaenisch, T.S. Mikkelsen, T. Jacks, N. Hacohen, B.E. Bernstein, M. Kellis, A. Regev, J.L. Rinn, and E.S. Lander Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals Nature 458 2009 223 227
36. N.D. Heintzman, G.C. Hon, R.D. Hawkins, P. Kheradpour, A. Stark, L.F. Harp, Z. Ye, L.K. Lee, R.K. Stuart, C.W. Ching, K.A. Ching, J.E. Antosiewicz-Bourget, H. Liu, X. Zhang, R.D. Green, V.V. Lobanenkov, R. Stewart, J.A. Thomson, G.E. Crawford, M. Kellis, and B. Ren Histone modifications at human enhancers reflect global cell-type-specific gene expression Nature 459 2009 108 112
37. O. Herrmann, B. Baumann, R. de Lorenzi, S. Muhammad, W. Zhang, J. Kleesiek, M. Malfertheiner, M. Köhrmann, I. Potrovita, I. Maegele, C. Beyer, J.R. Burke, M.T. Hasan, H. Bujard, T. Wirth, M. Pasparakis, and M. Schwaninger IKK mediates ischemia-induced neuronal death Nat. Med. 11 2005 1322 1329
38. J.E. Hoberg, A.E. Popko, C.S. Ramsey, and M.W. Mayo IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300 Mol. Cell. Biol. 26 2006 457 471
39. E. Hockly, V.M. Richon, B. Woodman, D.L. Smith, X. Zhou, E. Rosa, K. Sathasivam, S. Ghazi-Noori, A. Mahal, P.A. Lowden, J.S. Steffan, J.L. Marsh, L.M. Thompson, C.M. Lewis, P.A. Marks, and G.P. Bates Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease Proc. Natl. Acad. Sci. U. S. A. 100 2003 2041 2046
40. A. Hoffmann, T.H. Leung, and D. Baltimore Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities EMBO J. 22 2003 5530 5539
41. I. Inta, S. Paxian, I. Maegele, W. Zhang, M. Pizzi, P. Spano, I. Sarnico, S. Muhammad, O. Herrmann, D. Inta, B. Baumann, H.C. Liou, R.M. Schmid, and M. Schwaninger Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia J. Neurosci. 26 2006 12896 12903
42. C. Kaltschmidt, B. Kaltschmidt, and P.A. Baeuerle Brain synapses contain inducible forms of the transcription factor NF-kappa B Mech. Dev. 43 1993 135 147
43. B. Kaltschmidt, M. Uherek, H. Wellmann, B. Volk, and C. Kaltschmidt Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis Proc. Natl. Acad. Sci. U. S. A. 96 1999 9409 9414
44. M. Karin, and Y. Ben-Neriah Phosphorylation meets ubiquitination: the control of NF-kappaB activity Annu. Rev. Immunol. 18 2000 621 663
45. T.K. Kerppola Polycomb group complexes - many combinations, many functions Trends Cell Biol. 19 2009 692 704
46. R. Kiernan, V. Brès, R.W. Ng, M.P. Coudart, S. El Messaoudi, C. Sardet, D.Y. Jin, S. Emiliani, and M. Benkirane Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65 J. Biol. Chem. 278 2003 2758 2766
47. H.J. Kim, M. Rowe, M. Ren, J.S. Hong, P.S. Chen, and D.M. Chuang Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action J. Pharmacol. Exp. Ther. 321 2007 892 901
48. D. Kögel, M. Peters, H.G. König, S.M. Hashemi, N.T. Bui, V. Arolt, M. Rothermundt, and J.H. Prehn S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: clinical implications for the role of S100B in excitotoxic brain injury Neuroscience 127 2004 913 920
49. E. Koulich, T. Nguyen, K. Johnson, C. Giardina, and S. D'mello NF-kappaB is involved in the survival of cerebellar granule neurons: association of IkappaBβ phosphorylation with cell survival J. Neurochem. 76 2001 1188 1198
50. P.W. Laird Principles and challenges of genomewide DNA methylation analysis Nat. Rev. Genet. 11 2010 191 203
51. A. Lanzillotta, I. Sarnico, R. Ingrassia, F. Boroni, C. Branca, M. Benarese, G. Faraco, F. Blasi, A. Chiarugi, P. Spano, and M. Pizzi The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury Cell Death Dis. 1 2010 e96
52. F. Lezoualc'h, Y. Sagara, F. Holsboer, and C. Behl High constitutive NF-kappaB activity mediates resistance to oxidative stress in neuronal cells J. Neurosci. 18 1998 3224 3232
53. S.B. Maggirwar, P.D. Sarmiere, S. Dewhurst, and R.S. Freeman Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons J. Neurosci. 18 1998 10356 10365
54. J.S. Mattick Deconstructing the dogma: a new view of the evolution and genetic programming of complex organisms Ann. N. Y. Acad. Sci. 1178 2009 29 46
55. M.P. Mattson, and S. Camandola NF-kappaB in neuronal plasticity and neurodegenerative disorders J. Clin. Invest. 107 2001 247 254
56. M.P. Mattson, and M.K. Meffert Roles for NF-kappaB in nerve cell survival, plasticity, and disease Cell Death Differ. 13 2006 852 860
57. M.W. Mayo, C.E. Denlinger, R.M. Broad, F. Yeung, E.T. Reilly, Y. Shi, and D.R. Jones Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway J. Biol. Chem. 278 2003 18980 18989
58. M.F. Mehler Epigenetic principles and mechanisms underlying nervous system functions in health and disease Prog. Neurobiol. 86 2008 305 341
59. G. Middleton, M. Hamanoue, Y. Enokido, S. Wyatt, D. Pennica, E. Jaffray, R.T. Hay, and A.M. Davies Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons J. Cell Biol. 148 2000 325 332
60. R. Mittal, S.Y. Peak-Chew, and H.T. McMahon Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling Proc. Natl. Acad. Sci. U. S. A. 103 2006 18574 18579
61. A. Nurmi, P.J. Lindsberg, M. Koistinaho, W. Zhang, E. Juettler, M.L. Karjalainen-Lindsberg, F. Weih, N. Frank, M. Schwaninger, and J. Koistinaho Nuclear factor-kappaB contributes to infarction after permanent focal ischemia Stroke 35 2004 987 991
62. L.A. O'Neill, and C. Kaltschmidt NF-kappa B: a crucial transcription factor for glial and neuronal cell function Trends Neurosci. 20 1997 252 258
63. N.D. Perkins, L.K. Felzien, J.C. Betts, K. Leung, D.H. Beach, and G.J. Nabel Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator Science 275 1997 523 527
64. S. Petri, M. Kiaei, K. Kipiani, J. Chen, N.Y. Calingasan, J.P. Crow, and M.F. Beal Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis Neurobiol. Dis. 22 2006 40 49
65. M. Pizzi, and P. Spano Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms Eur. J. Pharmacol. 545 2006 22 28
66. M. Pizzi, F. Goffi, F. Boroni, M. Benarese, S.E. Perkins, H.C. Liou, and P. Spano Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukin-1beta J. Biol. Chem. 277 2002 20717 20723
67. M. Pizzi, I. Sarnico, F. Boroni, A. Benetti, M. Benarese, and P.F. Spano Inhibition of IkappaBalpha phosphorylation prevents glutamate-induced NF-kappaB activation and neuronal cell death Acta Neurochir. Suppl. 93 2005 59 63
68. M. Pizzi, I. Sarnico, F. Boroni, M. Benarese, N. Steimberg, G. Mazzoleni, G.P. Dietz, M. Bähr, H.C. Liou, and P.F. Spano NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicity Cell Death Differ. 12 2005 761 772
69. M. Pizzi, I. Sarnico, A. Lanzillotta, L. Battistin, and P. Spano Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability FEBS J. 276 2009 27 35
70. Z.H. Qin, R.W. Chen, Y. Wang, M. Nakai, D.M. Chuang, and T.N. Chase Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum J. Neurosci. 19 1999 4023 4033
71. M. Ren, Y. Leng, M. Jeong, P.R. Leeds, and D.M. Chuang Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction J. Neurochem. 89 2004 1358 1367
72. D.A. Ridder, and M. Schwaninger NF-kappaB signaling in cerebral ischemia Neuroscience 158 2009 995 1006
73. S. Rocha, M.D. Garrett, K.J. Campbell, K. Schumm, and N.D. Perkins Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor EMBO J. 24 2005 1157 1169
74. H. Ryu, K. Smith, S.I. Camelo, I. Carreras, J. Lee, A.H. Iglesias, F. Dangond, K.A. Cormier, M.E. Cudkowicz, R.H. Brown Jr., and R.J. Ferrante Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice J. Neurochem. 93 2005 1087 1098
75. I. Sarnico, F. Boroni, M. Benarese, M. Alghisi, A. Valerio, L. Battistin, P. Spano, and M. Pizzi Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes J. Neural. Transm. 115 2008 693 701
76. I. Sarnico, F. Boroni, M. Benarese, S. Sigala, A. Lanzillotta, L. Battistin, P. Spano, and M. Pizzi Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells J. Neural. Transm. 115 2008 669 676
77. I. Sarnico, A. Lanzillotta, F. Boroni, M. Benarese, M. Alghisi, M. Schwaninger, I. Inta, L. Battistin, P. Spano, and M. Pizzi NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia J. Neurochem. 108 2009 475 485
78. I. Sarnico, A. Lanzillotta, M. Benarese, M. Alghisi, C. Baiguera, L. Battistin, P. Spano, and M. Pizzi NF-kappaB dimers in the regulation of neuronal survival Int. Rev. Neurobiol. 85 2009 351 362 (Review)
79. A. Schneider, A. Martin-Villalba, F. Weih, J. Vogel, T. Wirth, and M. Schwaninger NF-kappaB is activated and promotes cell death in focal cerebral ischemia Nat. Med. 5 1999 554 559
80. U. Siebenlist, G. Franzoso, and K. Brown Structure, regulation and function of NF-kappa B Annu. Rev. Cell Biol. 10 1994 405 455
81. R.G. Urdinguio, J.V. Sanchez-Mut, and M. Esteller Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies Lancet Neurol. 8 2009 1056 1072
82. A. Valerio, F. Boroni, M. Benarese, I. Sarnico, V. Ghisi, L.G. Bresciani, M. Ferrario, G. Borsani, P. Spano, and M. Pizzi NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production Eur. J. Neurosci. 23 2006 1711 1720
83. A. Valerio, M. Dossena, P. Bertolotti, F. Boroni, I. Sarnico, G. Faraco, A. Chiarugi, A. Frontini, A. Giordano, H.C. Liou, M.G. De Simoni, P. Spano, M.O. Carruba, M. Pizzi, and E. Nisoli Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/c-Rel-dependent transcription Stroke 40 2009 610 617
84. P. Viatour, S. Legrand-Poels, C. van Lint, M. Warnier, M.P. Merville, J. Gielen, J. Piette, V. Bours, and A. Chariot Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3 J. Biol. Chem. 278 2003 46541 46548
85. C.H. Waddington The epigenotype Endeavour 1 1942 18 20
86. Z. Wang, C. Zang, J.A. Rosenfeld, D.E. Schones, A. Barski, S. Cuddapah, K. Cui, T.Y. Roh, W. Peng, M.Q. Zhang, and K. Zhao Combinatorial patterns of histone acetylations and methylations in the human genome Nat. Genet. 40 2008 897 903
87. A.E. West, E.C. Griffith, and M.E. Greenberg Regulation of transcription factors by neuronal activity Nat. Rev. Neurosci. 3 2002 921 931
88. Y. Yamamoto, U.N. Verma, S. Prajapati, Y.T. Kwak, and R.B. Gaynor Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression Nature 423 2003 655 659
89. F. Yeung, J.E. Hoberg, C.S. Ramsey, M.D. Keller, D.R. Jones, R.A. Frye, and M.W. Mayo Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase EMBO J. 23 2004 2369 2380
90. Z. Yu, D. Zhou, A.J. Bruce-Keller, M.S. Kindy, and M.P. Mattson Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury J. Neurosci. 19 1999 8856 8865
91. H. Zhong, R.E. Voll, and S. Ghosh Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300 Mol. Cell 1 1998 661 671
92. H. Zhong, M.J. May, E. Jimi, and S. Ghosh The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1 Mol. Cell 9 2002 625 636